Targeted Protein Degradation: From Small Molecules to Complex Organelles
Targeted Protein Degradation: From Small Molecules to Complex Organelles
批准号:
10237082
负责人:
Thale Cross Jarvis
金额:
$1.68万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-05-01 至 2022-04-30
关键词:
AcademiaAgeAreaAttentionAustriaAutomobile DrivingAutophagocytosisBasic ScienceCell physiologyCollaborationsComplexDegradation PathwayDiseaseEducational workshopExposure toFosteringFunctional disorderFuture GenerationsGoalsHealthHomeostasisIndustrializationIndustryKnowledgeMaintenanceMalignant NeoplasmsMartensMethodologyMethodsMolecularMolecular ChaperonesNerve DegenerationOrganellesOutcomePathologyPathway interactionsPeptide HydrolasesPhysiologicalPlayPositioning AttributeProcessProteinsProteomeResearchResearch PersonnelRoleScientistShapesSignal TransductionSpeedSystemTechniquesTherapeuticTranslationsUbiquitinVisioncareerclinical implementationclinical practicegender diversityinsightmulticatalytic endopeptidase complexnovelpostersprogramsprotein degradationsmall moleculesmall molecule therapeuticssymposiumtechnological innovation
中文摘要
摘要
要求支持一个Keystone专题讨论会,题为“靶向蛋白质降解:从小
分子到复杂的细胞器,由Sascha Martens,Tim Clausen和Judith Frydman博士组织。的
会议将于2021年6月6日至9日在奥地利维也纳举行。
靶向蛋白质降解在调节几乎所有细胞功能中起关键作用,因此,其
功能障碍与严重的病理学有关,包括癌症、神经变性和衰老等疾病,
相关疾病。因此,对蛋白质清除途径的基本见解可能会被利用,
用于治疗多种疾病。虽然在揭示人类的
自噬机制和泛素-蛋白酶体系统,主要的蛋白质降解途径
到目前为止,尽管这些领域相互关联,但它们仍然相互隔离。
流程.这种分离现在导致迫切需要讨论这些途径的相互作用,
分子和细胞水平,以整合我们对这些过程的理解,以及它们如何有助于
疾病病理学这次会议将汇集来自这些不同领域的研究人员,他们不
通常相互作用,以建立蛋白质降解的整体和综合愿景。这样一个综合
会议强调蛋白质降解研究的不同分支之间的联系,
目前还不存在,所以这次Keystone研讨会会议将是第一次重塑这些领域如何
互动和合作,对基础科学和疾病过程产生变革性的见解。主题
讨论的内容包括:(1)底物识别和能量依赖性蛋白酶加工,自噬
(2)将蛋白质靶向不同降解途径的信号;(3)
蛋白水解系统和伴侣蛋白途径;(4)用小分子重编程降解,
治疗应用;(5)降解程序驱动全球蛋白质组重塑。与会者将
接触新的观点,以及方法,技术和方法,这将推动研究
在他们的领域内,以及蛋白质降解景观中的许多不同组成部分。
英文摘要
ABSTRACT
Support is requested for a Keystone Symposia conference entitled Targeted Protein Degradation: From Small
Molecules to Complex Organelles, organized by Drs. Sascha Martens, Tim Clausen and Judith Frydman. The
conference will be held in Vienna, Austria from June 6-9, 2021.
Targeted protein degradation plays a critical role in regulating nearly all cellular functions, and as such, its
dysfunction is associated with severe pathologies including diseases like cancer, neurodegeneration and age-
associated diseases. Therefore, fundamental insights into protein clearance pathways might be harnessed for
therapeutic applications against a wide range of diseases. While much progress has been made in revealing
mechanisms of autophagy and the ubiquitin-proteasome system, the major protein degradation pathways
defined thus far, these fields continue to remain isolated from each other despite the interconnection of these
processes. This separation is now leading to an urgent need to discuss the interplay of these pathways at the
molecular and cellular levels to integrate our understanding of these processes and how they contribute to
disease pathology. This conference will bring together researchers from these different fields, who do not
typically interact, to build a holistic and integrated vision of protein degradation. Such an integrative
conference highlighting the connections between the different branches of protein degradation research does
not yet exist, so this Keystone Symposia conference will be the first of its kind to reshape how these fields
interact and collaborate to yield transformative insights into both basic science and disease processes. Topics
of discussion will include: (1) Substrate recognition and processing by energy-dependent proteases, autophagy
and lysosomal pathways; (2) Signals targeting proteins to distinct degradation pathways; (3) Interplay between
proteolytic systems and chaperone pathways; (4) Reprogramming degradation with small molecules for
therapeutic applications; (5) Degradation programs driving global proteome remodeling. Attendees will be
exposed to novel perspectives, as well as methods, techniques and approaches, that will advance research
within their field, and across the many different components in the protein degradation landscape.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bioenergetics in Health and Diseases
-
批准号:10609120
-
项目类别:
-
资助金额:$1.74万
-
财政年份:2023
-
负责人:Thale Cross Jarvis
-
依托单位:
Autophagy and Neurodegeneration: Mechanisms to Therapies
-
批准号:10608666
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:Thale Cross Jarvis
-
依托单位:
Adipose Tissue: Energizing Good Fat
-
批准号:10609127
-
项目类别:
-
资助金额:$2.02万
-
财政年份:2023
-
负责人:Thale Cross Jarvis
-
依托单位:
Cancer Neoantigens, Vaccines and Viruses
-
批准号:10233861
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Small Regulatory RNAs: From Bench to Bedside
-
批准号:10462420
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Engineering Multi-Cellular Living Systems
-
批准号:10462913
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Gut-Brain Axis
-
批准号:10467819
-
项目类别:
-
资助金额:$1.72万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Malaria: Confronting Challenges From Drug Discovery to Treatment
-
批准号:10468493
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
The Human Microbiome: Ecology and Evolution
-
批准号:10391370
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Modern Phenotypic Drug Discovery: From Chemical Biology to Therapeutics
-
批准号:10468419
-
项目类别:
-
资助金额:$1.72万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Progress in Vaccine Development for Infectious Diseases
-
批准号:10467880
-
项目类别:
-
资助金额:$0.55万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Tissue Fibrosis and Repair: Mechanisms, Human Disease and Therapies
-
批准号:10462412
-
项目类别:
-
资助金额:$1.8万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Drug Delivery to the Brain: Challenges and Progress
-
批准号:10540503
-
项目类别:
-
资助金额:$1.77万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Neurocircuitry of Social Behavior
-
批准号:10540465
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Resolution of Inflammation
-
批准号:10469175
-
项目类别:
-
资助金额:$0.9万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Organoids as Tools for Fundamental Discovery and Translation
-
批准号:10469084
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Novel Approaches Against Emerging Antimicrobial Resistance
-
批准号:10391767
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Precision Genome Engineering
-
批准号:10391367
-
项目类别:
-
资助金额:$2.22万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Neuronal Control of Appetite
-
批准号:10468571
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
Innate Immunity: Complement and Beyond
-
批准号:10464340
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2022
-
负责人:Thale Cross Jarvis
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: